Complex recombinant monoclonal antibodies (mAbs) are a growing class of biotherapeutics. mAbs are susceptible to chemical modification and degradation during production, formulation, and storage, and thus, identifying critical quality attributes (CQAs) is critical for development and production of biotherapeutics. Ensuring lot-to-lot consistency and quality of the product requires comprehensive analytical characterization.
In this webcast we will present Agilent samples to answers workflow solutions for monoclonal antibody characterization. The presentation covers analytical strategies for monitoring CQAs. We will focus on main quality attributes such as charge variants, aggregation, glycosylation, host cell protein impurities and post-translational modifications.
Key Learning Objectives:
Who Should Attend:
For Questions please contact, Kristen Moore: firstname.lastname@example.org